ARCHIVES

Phase II Study Cohort Fails To Overcome Erlotinib Resistance

This article is from The Cancer Letter archive.

Vol. 36 No. 4 | April 26, 2013

Download PDF Visit The Full Archive

Related Articles

Breast Cancer Coalition Widens Its Agenda For Advocacy, Vows To Fight NIH Cutbacks

May 5, 1995

NCI’s Richard Kaplan named associate director, National Cancer Research Network of UK.

January 2, 2004

Center Grant Review Tougher, Yarbro Insists

May 23, 1975

In Brief: David Nathan receives Lifetime Impact Award from Boston Children’s Hospital

November 7, 2014

Newell Reports Cancer Deaths In Younger Age Groups Dropping

March 18, 1977

Five Contracts Funded Under Unconventional Innovations Program

October 22, 1999